• SENSEX 76,617.44
    592.93 (+0.78%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Kalyan Jewellers
    519.15 794.60(%)
  • Dr Lal Pathlabs
    2,508.00 3,645.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Quadrant Future
    605.00 743.45(%)
  • Zomato Ltd
    212.60 304.50(%)
  • SRF
    2,986.25 3,074.95(%)
  • Bengal & Assam
    7,450.00 11,498.90(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Mazagon Dock
    2,610.00 2,929.98(%)
  • Suzlon Energy
    57.74 86.04(%)
  • SpiceJet
    46.10 79.90(%)
  • Dixon Technolog.
    13,485.00 19,149.80(%)
  • Adani Green
    944.95 2,173.65(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • M & M
    2,660.50 3,276.30(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Beryl Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3982.0
  • ISIN : INE415H01017
22.73 1 (6.46%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    21.80

  • Today’s High

    24.49

  • Open

    21.80

  • Perv Close

    21.35

  • 52W Low

    20.27

  • 52W High

    46.00

Key Indicators

  • P/E(TTM)

    142.06

  • Mar.Cap (₹Cr.)

    11.53

  • Div & Yield %

    0.00

  • Book Value(₹)

    18.30

  • Debt-Equity Ratio

    6.46

  • AGM Date

    02-Apr-2025

  • EPS

    0.16

  • P/E Ratio

    142.06

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    11.53

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.07

  • BV (₹)

    18.30

  • Sales( ₹ in Cr.)

    26.73

  • NP (in Cr.)

    0.76

  • NP Var(%)

    0.0

  • Div%

    0.0

  • CPS (₹)

    3.90

  • EPS (₹)

    1.50

  • Traded Value (₹ in Lakhs)

    10.83

  • 52 Week High

    46.00

  • 52 Week Low

    20.27

  • Price BSE

    21.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    10.83

  • P/C Ratio

    5.40

  • P/E Ratio

    14.00

  • Price Vs.BV

    1.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 26.73 26.89 14.60 14.09 12.82 12.96
Excise Duty 26.45 26.71 14.45 13.84 12.57 12.64
Net Sales 26.73 26.89 14.60 14.09 12.82 12.96
Other Income 0.40 0.27 0.16 0.19 0.23 0.24
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 27.12 27.16 14.77 14.28 13.04 13.20
EXPENDITURE :
Raw Materials 26.45 26.71 14.45 13.84 12.57 12.64
Power & Fuel Cost 26.45 26.71 14.45 13.84 12.57 12.64
Employee Cost 1.93 1.70 1.31 1.18 0.97 0.85
Other Manufacturing Expenses 0.37 0.12 0.26 0.07 0.02 0.10
Selling & Administrative Expenses 4.34 4.55 2.22 1.95 2.26 2.09
Miscellaneous Expenses 0.37 0.12 0.26 0.07 0.02 0.10
Less : Pre-operative Expenses Capitalised :
Total Expenditure 26.12 26.17 15.72 14.38 12.89 12.41
Operating Profit 4.67 4.03 2.03 2.03 2.05 1.92
Interest 0.46 0.42 0.41 0.46 0.32 0.15
Gross Profit 1.01 0.98 -0.95 0.35 0.16 0.80
Depreciation 1.20 0.81 1.09 1.27 0.66 0.32
Profit Before Tax 1.01 0.98 -0.95 0.35 0.16 0.80
Tax 0.43 0.16 0.00 0.00 -0.04 0.26
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.20 0.06 -0.30 0.11 0.15 -0.05
Reported Net Profit 0.77 0.77 -0.66 0.24 0.05 0.59
Extraordinary Items 1.01 0.98 -0.95 0.35 0.16 0.80
Adjusted Net Profit 0.77 0.77 -0.66 0.24 0.05 0.59
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 0.77 0.77 -0.66 0.24 0.05 0.59
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.52 1.51 -1.30 0.47 0.09 1.16
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    26.38%

  • Public Share Holding

    73.62%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,338,135 26.38 1,338,135 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,338,135 26.38 1,338,135 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 152,055 3.00 112,355 41
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 35,786 0.71 23,986 38
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 79,031 1.56 79,031 45
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 827,385 16.31 827,385 14
Individuals holding nominal share capital up to Rs. 1 lakh 2,639,308 52.04 1,427,308 7,287
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,733,565 73.62 2,470,065 7,425
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,071,700 100.00 3,808,200 7,429

Company Background

Beryl Drugs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Beryl Drugs Ltd
  • BSE Code : 3982.0
  • ISIN : INE415H01017

  • Incorporation Year

    1993

  • Registered Office

    133 Kanchan Bag
    , Indore,
    Madhya Pradesh-452001

  • Telephone

    91-731-25076375/3046366

  • FAX

    91-731-25065375/3046366

  • Chairman

    Sudhir Sethi

  • Managing Director

    Sanjay Sethi

  • Company Secretary

    Neha Sharma

  • Auditor

    Subhash Chand Jain Anurag & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Adroit Corp. Services Pvt Ltd
    19/20 Jaferbhoy Ind,
    1st Floor Makwana Rd,Marol Naka
    Mumbai - Mumbai - 400 059

Beryl Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Beryl Drugs 22.73 27.12 26.73 142.06 11.38
Abbott India 29,572.60 6,097.18 5,848.91 47.09 44.71
Astrazeneca Phar 8,100.10 1,330.33 1,295.53 208.82 33.26
P & G Health Ltd 5,259.35 1,166.89 1,151.26 36.90 39.76
Glaxosmi. Pharma 2,776.60 3,530.73 3,407.25 55.21 44.44
Cipla 1,452.70 17,645.00 16,574.34 24.90 20.10
Amrutanjan Healt 645.10 437.58 421.23 37.81 20.84
Fermenta Biotec. 292.05 315.24 307.09 27.68 4.10
Guj. Themis Bio. 272.20 174.19 169.82 56.36 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 37.31 11.70 3.81 15.94 1.92